The diabetes drug Avandia is linked with tens of thousands of heart attacks, and drugmaker GlaxoSmithKline knew of the risks for years but worked to keep them from the public, a Senate committee report released Saturday says.

Related PostsACIES Consecration Ceremony slated for March 7The Legion of Mary of the Fall River Diocese will hold the 58th annual “ACIES” Consecrat…New frontier in doping — genesSteroids are so 2008. The next way to get an edge may be gene doping.

Related PostsExercise …Do I look fat in these genes? Exercise can cancel out effects of ‘heavy-weight’ DNAMore evidence today that our genes aren’t always our destiny — with an inconvenient cave…Lawsuit filed over gene patentsAthletes With Asthma Need More Help From Their Team Trainers

Original post by Scientific American Topic - Exercise and Fitness